Pleased to share with you that Mutabilis team has recently joined Tamrisa - a newly created specialized pharma venture to tackle anti-microbial resistance through innovation, stewardship and access. Important evolution for our team, that allows us to secure our projects and diversify our financial resources. Follow us now on Tamrisa. Thank you for your support Wandrille Ract-Madoux Benoît Hennion Leopold Berthier SUBSTIPHARM Charlotte Lezius-Doncel Gregoire De Castelnau Stags Participations Nicolas Vennin Charlie Bryant Simple Pharma Weinberg Capital Partners CARB-X Roche REPAIR Impact Fund #AntiMicrobialResistance #AntibioticResistance #superbugs
Happy to introduce Tamrisa - a new specialized pharma venture to tackle anti-microbial resistance through innovation, stewardship and access. www.tamrisa.com #AntiMicrobialResistance #AntibioticResistance #superbugs